Adams Street Partners’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-16,285
Closed -$586K 29
2021
Q3
$586K Buy
+16,285
New +$641K 0.08% 23
2021
Q2
Sell
-114,661
Closed -$5.25M 26
2021
Q1
$5.25M Buy
+114,661
New +$6.58M 0.84% 13

Other funds holding LUNG

Adams Street Partners's LUNG Position: Q4 2021 in Review

Adams Street Partners sold out of Pulmonx (LUNG) in Q4 2021, closing a stake of 16,285 shares — an estimated $586K sold.

Adams Street Partners first reported a position in LUNG in Q1 2021 and held it in 2 quarters. The position peaked at $5.25M in Q1 2021. 114 funds tracked by Wall St. Rank hold LUNG as of Q4 2021.

  • Adams Street Partners reported no remaining Pulmonx position as of Q4 2021 after selling out during the quarter.
  • Adams Street Partners sold 16,285 Pulmonx shares in Q4 2021, an estimated $586K.
  • Adams Street Partners first reported a position in Pulmonx in Q1 2021 and held it in 2 quarters.
  • Adams Street Partners's Pulmonx position peaked at $5.25M in Q1 2021.
  • 114 funds tracked by Wall St. Rank held Pulmonx as of Q4 2021.

Based on Adams Street Partners's 13F filing for Q4 2021, filed 14 Feb 2022.